- Home
- Companies
- north america
- biopsy solutions
Show results for
Refine by
Biopsy Solutions Suppliers In North America
11 companies found
based inEdmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
based inPhoenix, ARIZONA (USA)
VisionGate, Inc., is a breakthrough liquid-biopsy technology company, leading the battle against lung cancer through early detection technology with a simple, non-intrusive sputum test. The foundation for our diagnostics capability is the ...
based inSunnyvale, CALIFORNIA (USA)
Since 1995, Intuitive has advanced minimally invasive care through advanced robotic systems, end-to-end learning, and value-added services. As one of the pioneers of robotic-assisted surgery, our da Vinci surgical system is used today by surgeons to ...
based inVancouver, BRITISH COLUMBIA (CANADA)
The TSK Group was founded in 1948 by the original founder Yonesaburou Kawashima, who later received the prestigious Order of the Rising Sun from emperor Akihito in 2011 for significant achievement and contribution to the nation for his work in the ...
based inSouth Jordan, UTAH (USA)
Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical ...
The lightweight, automatic Achieve device is spring-loaded for fast, accurate penetration. It gives you the precise control and quality sampling capability you need when working with calcified or fibrous lesions. You can conveniently operate the ...
based inOak Creek, WISCONSIN (USA)
Ad-Tech was founded in 1983 by a visionary and parent who knew first-hand how devastating neurological disease can be. Since then, we’ve had a singular focus on designing, engineering and supporting the world’s most sought-after devices. Surgeons, ...
Ad-Tech’s disposable brain biopsy needles offer you a time and cost effective alternative to expensive reusable brain biopsy needles. Importantly, their single-use design addresses your concerns regarding cross-contamination and ensures that ...
based inAurora, COLORADO (USA)
Triopsy Medical, Inc. manufacturer of Cancer Diagnosis system. Our new Triopsy approach will create opportunity across three key market segments: medical device, pathology systems, and mapping systems for more accurate diagnosis. Our novel biopsy ...
based inCincinnati, OHIO (USA)
Mammotome is proud to celebrate 25 years of innovation. Learn how we transformed the future of breast cancer diagnostics and continue to discover new opportunities to deliver better solutions and care. At Mammotome, we are a global team dedicated to ...
Provides procedural efficiency with large, contiguous cores for a complete and accurate pathological diagnosis. ...
based inCambridge, UNITED KINGDOM
Owlstone Medical is developing a breathalyzer for disease. With a goal to find ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health and other conditions. Our mission is to save 100,000 lives and ...
Owlstone Medical’s patented FAIMS technology can be applied to rapidly monitor a broad range of volatile compounds from breath, urine and other bodily fluids with high sensitivity and ...
based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...
